麻豆传媒

Dr. Christopher J. Johnson received his Ph.D. in Sociology with a major in Aging and Family and minor in Social Psychology from Iowa State University, Sociology with major in Aging and Family. He earned his M.A. from University of Northern Iowa in Sociology with major in Aging. He earned his B.A. in Philosophy from the University of Denver. In research, besides procuring over 3 million dollars in grant and private funding, his interests are in dementia and marriage, design for dementia, suicide, thanatology and religiosity and aging. At his previous university, he was twice awarded 鈥淩esearcher of the Year鈥� in the School of Arts and Sciences.  He has conducted a state-wide needs assessment of elderly in Iowa but specializes in oral histories. He was awarded an, Endowed Professorship in Gerontology based upon his outstanding teaching and research skills.  

Jennifer Perion recently graduated with a PhD in the Health Education from the University of Toledo. She is interested in families and primarily conducts research related to aging with a concentration on the social aspects of dementia. Jennifer is a Certified Health Education Specialist (CHES), a Certified Quality Matters Higher Education Peer Reviewer, and she has a Master Online Instructor Program Certificate. Dr. Perion has college teaching experience for both in-person and online courses and will be joining The University of Tennessee as an Assistant Professor of Practice in the fall of 2021.

Dr Liz Coulthard is Associate Professor in Dementia Neurology in the Bristol Medical School and a specialist in cognitive neurology applied to dementia. Her research goal is to identify and to treat early cognitive deficits in Alzheimer鈥檚 disease with the aim of improving quality of life and slowing disease progression. Her current research sees her investigating the use of dopamine in enhancing older people鈥檚 sleep and memory. She is also a champion of how proper sleep patterns can bring about significant physical and mental health gains. In 2021, the work of Dr Coulthard and her team was recognised by sleep technology and app design company Dreem, which provided them with specialist sleep measuring devices for their work on the understanding of sleep, circadian rhythms and dopamine in neurodegenerative disease. After her training as a doctor, Dr Coulthard was appointed as a consultant and has founded a dedicated research group: the ReMemBr group (Research into Memory, the Brain and Dementia), a vibrant and expanding multidisciplinary clinical research group within which clinicians and researchers work side by side.

Education
1996 - BA - St John鈥檚 College, Oxford, 
1999 - M.B.B.S, Royal Free and University College Hospitals Medical School, 
2008 - PhD, University of London

Accomplishments
1999 - Merit Award in Clinical Pharmacology, 
2008 - First runner up prize, Queen Square Symposium poster competition, 
2015 - Fellow of the Royal College of Physicians UK

Domenico Praticò is a Professor of Neural Science at the . He obtained his medical degree from the University of Rome “La Sapienza” School of Medicine, where he also completed a residency program in Internal Medicine. He continued his post-graduate training as a Research Fellow of the Center for Cardiovascular Science at the University College, Dublin, Ireland. Next, he pursued a postdoctoral fellowship in the biology of aging at the University of Pennsylvania, where shortly after he was promoted to Assistant Professor, and later Associate Professor. In 2007 he joined Temple University, School of Medicine, as Associate Professor and Director of the Neurodegenerative Diseases Research Laboratory. Since 2011 he has been Professor of Neural Sciences at the Lewis Katz School of Medicine. In December 2017, he was nominated the Scott Richards North Star Foundation Chair in Alzheimer’s research and appointed as the founding Director of the Alzheimer’s Center at Temple. His main area of investigation is clinical pharmacology with a special focus on the cellular and molecular mechanisms involved in brain health, brain aging, and the pathogenesis of neurodegenerative diseases such as Alzheimer’s Disease and Frontotemporal Dementia. His early research includes pioneering work on the development of specific and sensitive methods to measure oxidative stress in vivo, which was instrumental for the first demonstration that brain oxidative stress is an early event in Alzheimer’s Disease pathogenesis. In addition, his work helped in defining the source and functional role that neuroinflammation plays in neurodegeneration. Pratico’s lab has been on the forefront in the effort to unravel the mechanisms responsible for the effect that dietary lifestyle has on brain health, providing evidence that extra virgin olive oil beneficial effects are secondary to the activation of important intracellular degradation pathways of unwanted materials. His group was the first to demonstrate that intracellular sorting and transport of protein is essential for neuronal health and that it can be a viable therapeutic target when it is dysfunctional. During these years, the main goal of his work has always been translating studies of the basic biology of brain aging and neurodegeneration into new therapeutics by implementing a comprehensive experimental approach which combines in vitro and in vivo models as well as human studies. Internationally known for his work on Alzheimer’s disease, brain health, aging and neurodegeneration, Dr. Pratico has authored over 290 original articles in high impact journals, and more than 25 chapters in thematic books. During his career, he has received many awards for his research accomplishments including the Irvine H. Page Award, Neuroscience Education and Research Award, Zenith Award from the Alzheimer’s Association, and Dorothy Dillon Eweson Lectureship from the American Federation for Aging Research, and the Paul W. Eberman Faculty Research Award, and The Marconi Science Award.